フルクトース-1,6-ビスホスファターゼ阻害剤としての新規イミダゾールカルボキサミド誘導体、およびそれを含む医薬組成物

Japanese Patent JP5026421

B2

Imidazole carboxamides (I) are new. Imidazole carboxamides of formula (I) and their tautomers, enantiomers, diastereoisomers, epimers and organic or mineral salts are new. R = OH, OR 15> or NR 11>R 12>; R 11>, R 12> = H or Z; or NR 11>R 12> = ring containing 1-3 heteroatoms, optionally fused and/or optionally substituted by 1-3 Y 1>; R 15> = 1-8C alkyl, 2-20C alkenyl, 2-20C alkynyl, 3-8C cycloalkyl (all optionally substituted by T 1>), 3-8C heterocycloalkyl (containing N, O or S and optionally substituted by halo, 1-8C alkyl or 1-8C alkoxy), 6-14C (hetero)aryl or or 6-14C (hetero)aryl(1-20C alkyl) (both optionally substituted by T 2>); T 1> = halo, 1-8C alkyl, 1-8C alkoxy, 3-8C cycloalkyl or 6-14C aryl; T 2> = amino, OH, SH, halo, 1-8C alkyl, 1-8C alkoxy, 1-8C alkylthio, 1-8C alkylamino, 6-14C aryl, 6-14C aryloxy or 6-14C aryl(1-8C alkoxy); R 1> = C(O)R 2> or C(O)NHR 2>; R 2> = Z; A = bond or divalent radical obtained by removal of one H from 1-20C alkyl, 2-20C alkenyl, 2-20C alkynyl, 1-20C alkoxy, 1-20C alkoxy(1-20C alkyl), 1-20C alkylthio, 1-20C alkylthio(1-20C alkyl), 1-20C alkylamino or 1-20C alkylamino(1-20C alkyl) (all optionally substituted by one or more Y 1>); D = bond or divalent radical obtained by removal of one H from 1-20C (oxy)alkyl, 2-20C (oxy)alkenyl, 2-20C (oxy)alkynyl, 1-20C alkoxy(1-20C alkyl), 1-20C alkylthio(1-20C alkyl), 1-20C alkylamino(1-20C alkyl), 1-20C thioalkyl, 2-20C (thio)alkenyl or 2-20C (thio)alkynyl (all optionally substituted by one or more Y 1>); X = bond or divalent radical obtained by removal of one H from 6-14C aryl, 5-14C heteroaryl (optionally containing O, N or S), 3-8C alkyl, 4-8C cycloalkenyl, 3-8C heterocycloalkyl (optionally containing O, N or S) (all optionally substituted by one or more Y 1>); or AXD = bond; Y 1> = OH, SH, halo, CN, OCF 3, CF 3, COOH, carboxymethyl, carboxyethyl, 1-8C alkyl, 1-8C alkoxy, 1-8C alkylamino, 6-14C aryl, 6-14C arylsulfonyl(1-8C alkyl), 6-14C aryloxy, 6-14C aryl(1-14C alkoxy), amino, azido, nitro, guanidino, amidino, phosphono, O, carbamoyl, 1-8C alkylsulfonyl, 1-8C alkylsulfinyl or 1-8C alkylthio; or Y 1>Y 1> = methylenedioxy; and Z = 6-14C (hetero)aryl, 6-14C (hetero)aryl-1-20C (oxy)alkyl, 6-14C (hetero)aryl(1-20C alkoxy)1-20C alkyl, 6-14C (hetero)aryl(1-20C thioalkyl), 6-14C (hetero)aryl(1-20C alkyl)1-20C thioalkyl, 3-8C (hetero)cycloalkyl, 3-8C (hetero)cycloalkyl(1-20C (oxy)alkyl), 3-8C (hetero)cycloalkyl(1-20C alkoxy)1-20C alkyl, 3-8C (hetero)cycloalkyl(1-20C thioalkyl), 3-8C (hetero)cycloalkyl(1-20C alkyl)1-20C thioalkyl, (6-14C (hetero)aryl)2-20C alkenyl, (6-14C (hetero)aryl)2-20C alkynyl (all optionally contain N, O or S) or 1-20C alkyl (all optionally substituted by one or more Y 1>). An independent claim is included for preparation of (I). [Image] ACTIVITY : Antidiabetic; Cardiovascular-Gen.; Antiarteriosclerotic; Cardiant; Antilipemic. MECHANISM OF ACTION : Fructose-1,6-biphosphatase inhibitor. The ability of (I) to inhibit fructose-1,6-biphosphatase was tested in human liver recombinant fructose-1,6-biphosphatase. Results showed that 5-[5-(4-tert-butylbenzoylamino)-4-carbamoyl-1H-imidazol-2-ylmethyl]furan-2-carboxylic acid exhibited IC 50 of 23 mu M.

Moine, Gerard
Boton, Gerard
Alberrod Vacu, Annik

JP2008524380A

September 12, 2012

July 07, 2006

Click for automatic bibliography generation  

Merck Patent Gesellschaft mit beschraenkter Haftung

C07D233/90; A61K31/4164; A61K31/4178; A61K31/5377; A61P3/06; A61P3/08; A61P3/10; A61P9/00; A61P9/10; A61P43/00; C07D405/04; C07D405/06; C07D409/04; C07D409/06

JP3504728A
JP2002524463A

WO1997031900A1
WO2007019937A1

VOET,A.B.,BIOORGANIC CHEMISTRY,1983年,V12 N1,P8-17
SHAW G,JOURNAL OF THE CHEMICAL SOCIETY,英国,CHEMICAL SOCIETY,1959年,P1648-1655

Akio Miyazaki
Ishibashi Masayuki
Masaaki Ogata

Previous Patent: JPS5026420

Next Patent: JPS5026422